Xuedong Chi

526 total citations
8 papers, 406 citations indexed

About

Xuedong Chi is a scholar working on Pathology and Forensic Medicine, Neurology and Oncology. According to data from OpenAlex, Xuedong Chi has authored 8 papers receiving a total of 406 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Pathology and Forensic Medicine, 3 papers in Neurology and 2 papers in Oncology. Recurrent topics in Xuedong Chi's work include Neurological Disease Mechanisms and Treatments (2 papers), Alzheimer's disease research and treatments (2 papers) and Lymphoma Diagnosis and Treatment (2 papers). Xuedong Chi is often cited by papers focused on Neurological Disease Mechanisms and Treatments (2 papers), Alzheimer's disease research and treatments (2 papers) and Lymphoma Diagnosis and Treatment (2 papers). Xuedong Chi collaborates with scholars based in United States, Canada and Germany. Xuedong Chi's co-authors include E. T. Sutton, J. M. Price, Gary Hellermann, Kerry J. Savage, Emily K. Larsen, Ajay K. Gopal, Joseph D. Rosenblatt, Robert Chen, Andreas Engert and Joseph M. Connors and has published in prestigious journals such as Blood, Clinical Cancer Research and British Journal of Pharmacology.

In The Last Decade

Xuedong Chi

7 papers receiving 398 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Xuedong Chi United States	7	203	181	86	84	67	8	406
Gabriele Hübinger Germany	10	76 0.4×	144 0.8×	168 2.0×	199 2.4×	44 0.7×	11	492
Benjamin I. Rubin United States	12	215 1.1×	268 1.5×	48 0.6×	202 2.4×	230 3.4×	14	806
Ivana Huvar United States	7	114 0.6×	46 0.3×	100 1.2×	353 4.2×	109 1.6×	8	611
Yasuo Kuroki Japan	13	101 0.5×	47 0.3×	33 0.4×	149 1.8×	39 0.6×	20	449
Hiroko Fukushima Japan	12	99 0.5×	84 0.5×	32 0.4×	127 1.5×	79 1.2×	35	506
Chun Ho Song South Korea	9	75 0.4×	35 0.2×	87 1.0×	137 1.6×	29 0.4×	18	378
Huy Q. Ta United States	12	159 0.8×	77 0.4×	35 0.4×	266 3.2×	17 0.3×	24	605
Céline Ruegsegger Switzerland	7	114 0.6×	35 0.2×	32 0.4×	173 2.1×	136 2.0×	8	430
Zhishuo Ou United States	9	90 0.4×	106 0.6×	38 0.4×	257 3.1×	16 0.2×	23	423
Gisele Oler Brazil	12	154 0.8×	64 0.4×	24 0.3×	274 3.3×	19 0.3×	15	637

Countries citing papers authored by Xuedong Chi

Since Specialization

Citations

This map shows the geographic impact of Xuedong Chi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xuedong Chi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xuedong Chi more than expected).

Fields of papers citing papers by Xuedong Chi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xuedong Chi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xuedong Chi. The network helps show where Xuedong Chi may publish in the future.

Co-authorship network of co-authors of Xuedong Chi

This figure shows the co-authorship network connecting the top 25 collaborators of Xuedong Chi. A scholar is included among the top collaborators of Xuedong Chi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xuedong Chi. Xuedong Chi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

Gopal, Ajay K., Barbara Pro, Joseph M. Connors, et al.. (2016). Response assessment in lymphoma: Concordance between independent central review and local evaluation in a clinical trial setting. Clinical Trials. 13(5). 545–554.

Gopal, Ajay K., Robert Chen, Scott E. Smith, et al.. (2014). Durable remissions in a pivotal phase 2 study of brentuximab vedotin in relapsed or refractory Hodgkin lymphoma. Blood. 125(8). 1236–1243. 158 indexed citations

Vergunst, Clarissa E., Daniëlle M. Gerlag, Lisa Von Moltke, et al.. (2009). MLN3897 plus methotrexate in patients with rheumatoid arthritis: Safety, efficacy, pharmacokinetics, and pharmacodynamics of an oral CCR1 antagonist in a phase IIa, double‐blind, placebo‐controlled, randomized, proof‐of‐concept study. Arthritis & Rheumatism. 60(12). 3572–3581. 52 indexed citations

Jones, J. Shawn, Xuedong Chi, Xiangjun Gu, et al.. (2004). p53 Polymorphism and Age of Onset of Hereditary Nonpolyposis Colorectal Cancer in a Caucasian Population. Clinical Cancer Research. 10(17). 5845–5849. 60 indexed citations

Chi, Xuedong, et al.. (2003). Prevention of cultured rat stellate cell transformation and endothelin‐B receptor upregulation by retinoic acid. British Journal of Pharmacology. 139(4). 765–774. 19 indexed citations

Price, J. M., Xuedong Chi, Gary Hellermann, & E. T. Sutton. (2001). Physiological levels ofβ-amyloid induce cerebral vessel dysfunction and reduce endothelial nitric oxide production. Neurological Research. 23(5). 506–512. 76 indexed citations

Chi, Xuedong, E. T. Sutton, Gary Hellermann, & J. M. Price. (2000). Potassium channel openers prevent β-amyloid toxicity in bovine vascular endothelial cells. Neuroscience Letters. 290(1). 9–12. 24 indexed citations

Chi, Xuedong, E. T. Sutton, Tom Thomas, & J. M. Price. (1999). The protective effect of K+ channel openers on ^-amyloid induced cerebrovascular endothelial dysfunction. Neurological Research. 21(4). 345–351. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact